scispace - formally typeset
P

Peter Goldstraw

Researcher at National Institutes of Health

Publications -  231
Citations -  28207

Peter Goldstraw is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lung cancer & Lung cancer staging. The author has an hindex of 68, co-authored 231 publications receiving 25178 citations. Previous affiliations of Peter Goldstraw include Harefield Hospital & National Health Service.

Papers
More filters
Journal ArticleDOI

Acute lung injury and acute respiratory distress syndrome after pulmonary resection

TL;DR: Patients that underwent pulmonary resection at the Royal Brompton Hospital between 1991 and 1997 were included and the case notes of all patients developing postoperative complications were retrospectively reviewed.
Journal ArticleDOI

Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.

TL;DR: Activated alveolar epithelium is an important source of chemokines that orchestrate leukocyte migration to the peripheral lung; early release of TNF-α and IL-1β by stimulated macrophages may contribute to alveolars epithelial cell activation and chemokine production.
Journal ArticleDOI

High resolution computed tomography as a predictor of lung histology in systemic sclerosis

TL;DR: Assessment of the ability of high resolution computed tomography to predict the histological appearance of open lung biopsy specimens from patients with systemic sclerosis found a significant association between a fibrotic Histological appearance and a grade 4 computed tomogram, and between an inflammatory histological appearances and a level 3 computed tomograms.
Journal ArticleDOI

The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer

Frank C. Detterbeck, +164 more
TL;DR: An extensive analysis has produced stage classification proposals for lung cancer with a robust degree of discriminatory consistency and general applicability and external validation is encouraged to identify areas of strength and weakness.